Regulatory protein from human keratinocytes
CA 2342957 A1 · Owner: Reinartz, Jeanette · Inventors: Bechtel, Michael; Kramer, Michael; Reinartz, Jeanette
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to an isolated polypeptide which is equivalent to or similar (i.e. equivalent in function and effect) to a protein which is naturally occurring in human keratinocytes and which is increasingly expressed in the activated state of the keratinocytes. The invention also relates to an isolated nucleic acid encoding such a polypeptide or protein typical of human keratinocytes, as well as to the use of said polypeptide and said nucleic acid for the purpose of assays, particularly for diagnostic purposes and/or for , therapeutic purposes, or to the use of reagents particularly of recombinant , vector molecules and antibodies directed against such molecules. The inventive …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 6, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 6, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 6, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.